Medicare Enrolled

Dr. Nicole Stranch, M.D.

Radiation Oncology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5323 HARRY HINES BLVD, Dallas, TX 75390
3186178427
In practice since 2015 (11 years)
NPI: 1245623685 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stranch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stranch? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stranch

Dr. Nicole Stranch is a radiation oncology specialist in Dallas, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Stranch performed 2,189 Medicare services across 2,180 unique beneficiaries.

Between the years covered by Open Payments, Dr. Stranch received a total of $255 from 3 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stranch is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 46% volume in TX $255 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,189
Medicare services
Top 46% in TX for radiation oncology
2,180
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~199 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Screening mammography 536 $35 $152
3D screening mammography (tomosynthesis) 475 $28 $117
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 205 $19 $150
Limited ultrasound scan of 1 breast 164 $23 $149
Diagnostic mammography of 1 breast 153 $26 $152
Diagnostic mammography of both breasts 153 $32 $191
Chest X-ray, 1 view 138 $6 $36
CT scan of head/brain, without contrast 71 $27 $228
Bone density scan (DEXA) 51 $9 $76
Ct scan of chest with contrast 30 $39 $315
Biopsy of breast and placement of locating device using ultrasound, first growth 29 $104 $1,100
Chest X-ray, 2 views 28 $7 $43
CT scan of abdomen and pelvis with contrast 24 $56 $399
Complete ultrasound scan of 1 breast 20 $27 $226
CT scan of chest, without contrast 19 $35 $293
Ct scan of abdomen and pelvis without contrast 17 $52 $382
Ct scan of upper spine without contrast 16 $31 $273
X-ray of abdomen, 1 view 16 $6 $36
Ultrasound study of arm or leg veins with compression and maneuvers 16 $25 $155
Biopsy of breast and placement of locating device using x-ray with needle, first growth 15 $123 $1,200
Ct scan of blood vessels of chest with contrast 13 $58 $420
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$255
Total received (2018-2024)
Avg $85/year across 3 years
Top 45% in TX for radiation oncology
3
Companies
3
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$255 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$134
2022
$16
2018
$106

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Change Healthcare Technologies, LLC
$134
GlaxoSmithKline, LLC.
$106
Bard Peripheral Vascular, Inc.
$16
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
BEXSERO · Change Healthcare Radiology Solutions
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12 per 100 Medicare services performed
Looking for a radiation oncology specialist in Dallas?
Compare radiation oncologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
624
Per 100K population
24.0
County median income
$74,149
Nearest hospital
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Stranch is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Stranch experienced with screening mammography?
Based on Medicare claims data, Dr. Stranch performed 536 screening mammography services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stranch receive payments from pharmaceutical companies?
Yes. Dr. Stranch received a total of $255 from 3 companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stranch's costs compare to other radiation oncologists in Dallas?
Dr. Stranch's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stranch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →